Mechanism of increased efficacy of recombinant Fc‐μTP‐L309C compared to IVIg to ameliorate mouse immune thrombocytopenia
Abstract Recombinant Fc‐μTP‐L309C is more efficacious than intravenous immunoglobulin (IVIg) at ameliorating antibody‐mediated autoimmune diseases through its effects on Fcγ receptors (FcγRs). Fc‐μTP‐L309C inhibited in‐vitro FcγR‐mediated phagocytosis 104/105‐fold better than IVIg. Fc‐μTP‐L309C, giv...
| Published in: | eJHaem |
|---|---|
| Main Authors: | Bonnie J.B. Lewis, Beth Binnington, Megan Blacquiere, Rolf Spirig, Fabian Käsermann, Donald R. Branch |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-11-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jha2.304 |
Similar Items
Maternal Immune Thrombocytopenic Purpura Leading to Severe Neonatal Autoimmune Thrombocytopenia: Report of Two Cases
by: Khushwant Kaur, et al.
Published: (2024-10-01)
by: Khushwant Kaur, et al.
Published: (2024-10-01)
Treatment of Immune Thrombocytopenia: Contextualization from a Historical Perspective
by: Daniel Martínez-Carballeira, et al.
Published: (2024-06-01)
by: Daniel Martínez-Carballeira, et al.
Published: (2024-06-01)
Older Adults and Immune Thrombocytopenia: Considerations for the Clinician
by: Crickx E, et al.
Published: (2023-01-01)
by: Crickx E, et al.
Published: (2023-01-01)
Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
by: Zahra Farahmandinia, et al.
Published: (2010-10-01)
by: Zahra Farahmandinia, et al.
Published: (2010-10-01)
Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
by: Zahra Farahmandinia, et al.
Published: (2010-12-01)
by: Zahra Farahmandinia, et al.
Published: (2010-12-01)
Iraqi consensus recommendations for the diagnosis and management of immune thrombocytopenia
by: Ahmed Mjali, et al.
Published: (2025-12-01)
by: Ahmed Mjali, et al.
Published: (2025-12-01)
IVIG Treatment Response and Age are Important for the Prognosis of Pediatric Immune Thrombocytopenia
by: Min Gi Sakong, et al.
Published: (2022-10-01)
by: Min Gi Sakong, et al.
Published: (2022-10-01)
The therapeutic window of intravenous immunoglobulin (IVIG) and its correlation with clinical outcomes in Kawasaki disease: a systematic review and meta-analysis
by: Zheng Li, et al.
Published: (2023-04-01)
by: Zheng Li, et al.
Published: (2023-04-01)
Immune thrombocytopenia in Kabuki syndrome, a comparison with non-Kabuki cases in the UK paediatric ITP registry
by: Lianna Reynolds, et al.
Published: (2025-05-01)
by: Lianna Reynolds, et al.
Published: (2025-05-01)
Immune thrombocytopenia in adolescents and young adults
by: Alexandra Schifferli
Published: (2025-03-01)
by: Alexandra Schifferli
Published: (2025-03-01)
FcγRIIa and FcγRIIIa genes polymorphism in Egyptian children with primary immune thrombocytopenia
by: Marwa Zakaria, et al.
Published: (2023-01-01)
by: Marwa Zakaria, et al.
Published: (2023-01-01)
Editorial: Immune thrombocytopenia (ITP)—diagnosis and treatment
by: Tomás José González-López
Published: (2024-03-01)
by: Tomás José González-López
Published: (2024-03-01)
Treatment of immune thrombocytopenia (ITP) secondary to malignancy: a systematic review
by: Gian Marco Podda, et al.
Published: (2022-01-01)
by: Gian Marco Podda, et al.
Published: (2022-01-01)
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis
by: Dorela Lame, et al.
Published: (2024-03-01)
by: Dorela Lame, et al.
Published: (2024-03-01)
Experience with Pediatric Chronic Immune Thrombocytopenia over 30 Years in the Era before Eltrombopag
by: Begum S. Koc, et al.
Published: (2024-08-01)
by: Begum S. Koc, et al.
Published: (2024-08-01)
Lifting the fog over ITP
by: Philip Young-Ill Choi
Published: (2020-04-01)
by: Philip Young-Ill Choi
Published: (2020-04-01)
Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched study
by: Arthur Mageau, et al.
Published: (2023-12-01)
by: Arthur Mageau, et al.
Published: (2023-12-01)
Impact of different treatment strategies on therapeutic efficacy and biomarkers in children with IVIG-resistant Kawasaki disease: a retrospective cohort study
by: Xin Zhou, et al.
Published: (2025-06-01)
by: Xin Zhou, et al.
Published: (2025-06-01)
Response to rituximab in children and adults with immune thrombocytopenia (ITP)
by: Emily M. Harris, et al.
Published: (2021-08-01)
by: Emily M. Harris, et al.
Published: (2021-08-01)
Thrombocytopenia induced by clopidogrel: a rare adverse effect
by: Catarina Távora, et al.
Published: (2023-10-01)
by: Catarina Távora, et al.
Published: (2023-10-01)
Clinical Phenotype and Response to Different Lines of Therapy in Elderly with Immune Thrombocytopenia: A Retrospective Study
by: Mancuso S, et al.
Published: (2020-08-01)
by: Mancuso S, et al.
Published: (2020-08-01)
Therapeutic effects of IVIG on oxaliplatin-induced spleen and intestinal injuries in mice
by: Yuyan QIN, et al.
Published: (2023-04-01)
by: Yuyan QIN, et al.
Published: (2023-04-01)
Treatment of patients with refractory immune thrombocytopenia: literature review and case report
by: V. V. Ptushkin, et al.
Published: (2014-07-01)
by: V. V. Ptushkin, et al.
Published: (2014-07-01)
Treatment of patients with refractory immune thrombocytopenia: literature review and case report
by: V. V. Ptushkin, et al.
Published: (2014-07-01)
by: V. V. Ptushkin, et al.
Published: (2014-07-01)
Low serum vitamin D levels in Iranians with immune thrombocytopenia: A single-center study
by: Mahsa Matinkia, et al.
Published: (2021-11-01)
by: Mahsa Matinkia, et al.
Published: (2021-11-01)
Retrospective Evaluation of Survival and Prognostic Factors in Immune Thrombocytopenia: A Single-Center and Cross-Sectional Study
by: Gökhan Pektaş, et al.
Published: (2024-07-01)
by: Gökhan Pektaş, et al.
Published: (2024-07-01)
Thymic-derived tolerizing dendritic cells are upregulated in the spleen upon treatment with intravenous immunoglobulin in a murine model of immune thrombocytopenia
by: Rick Kapur, et al.
Published: (2017-07-01)
by: Rick Kapur, et al.
Published: (2017-07-01)
Prevalence and eradication of Helicobacter pylori infection in immunological thrombocytopenia: Experience of the hematology department of the Sidi Bel-Abbes University Hospital.
by: Karima TAYEBI, et al.
Published: (2025-03-01)
by: Karima TAYEBI, et al.
Published: (2025-03-01)
Predictors of Remission in Severe Childhood Immune Thrombocytopenia
by: Chao-Neng Cheng, et al.
Published: (2023-01-01)
by: Chao-Neng Cheng, et al.
Published: (2023-01-01)
Immune Thrombocytopenia (ITP): Current Limitations in Patient Management
by: Deirdra R. Terrell, et al.
Published: (2020-11-01)
by: Deirdra R. Terrell, et al.
Published: (2020-11-01)
Immune thrombocytopenia in 2 healthy young women after the Pfizer‐BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination
by: Emilie C. Collins, et al.
Published: (2021-10-01)
by: Emilie C. Collins, et al.
Published: (2021-10-01)
IVIG-Associated Maternal Pancytopenia during Treatment for Neonatal Alloimmune Thrombocytopenia
by: Alyssa Herrmann, et al.
Published: (2017-07-01)
by: Alyssa Herrmann, et al.
Published: (2017-07-01)
Neonatal Alloimmune Thrombocytopenia Detected After Traumatic Delivery: Case Report
by: Gökhan Kaya, et al.
Published: (2021-08-01)
by: Gökhan Kaya, et al.
Published: (2021-08-01)
Eltrombopag-Induced Myelofibrosis in Patients with Adult Immune Thrombocytopenia: Scoping Review
by: Iman Moustafa, et al.
Published: (2019-08-01)
by: Iman Moustafa, et al.
Published: (2019-08-01)
Guidelines of Russian Expert Council on diagnostic and therapy of patients with primary immunne thrombocytopenia
by: A. A. Maschan, et al.
Published: (2022-11-01)
by: A. A. Maschan, et al.
Published: (2022-11-01)
Prevalence of Immune Thrombocytopenia Purpura in Wasit Province
by: Rawan Alaa
Published: (2024-09-01)
by: Rawan Alaa
Published: (2024-09-01)
Report of a ‘consensus’ on the lines of therapy for primary immune thrombocytopenia in adults, promoted by the Italian Gruppo di Studio delle Piastrine
by: Lorenzo Cirasino, et al.
Published: (2020-05-01)
by: Lorenzo Cirasino, et al.
Published: (2020-05-01)
Idiopathic Autoimmune Thrombocytopenic Purpura (ITP) in adult; review of 50 cases admitted to Baghdad teaching hospital.
by: Adil S. Al-Aqabi, et al.
Published: (2010-07-01)
by: Adil S. Al-Aqabi, et al.
Published: (2010-07-01)
Novel scientific approaches and future research directions in understanding ITP
by: Sarah M. Hicks, et al.
Published: (2020-04-01)
by: Sarah M. Hicks, et al.
Published: (2020-04-01)
Megakaryocytic dysfunction in immune thrombocytopenia is linked to autophagy
by: Rui-jie Sun, et al.
Published: (2019-03-01)
by: Rui-jie Sun, et al.
Published: (2019-03-01)
Similar Items
-
Maternal Immune Thrombocytopenic Purpura Leading to Severe Neonatal Autoimmune Thrombocytopenia: Report of Two Cases
by: Khushwant Kaur, et al.
Published: (2024-10-01) -
Treatment of Immune Thrombocytopenia: Contextualization from a Historical Perspective
by: Daniel Martínez-Carballeira, et al.
Published: (2024-06-01) -
Older Adults and Immune Thrombocytopenia: Considerations for the Clinician
by: Crickx E, et al.
Published: (2023-01-01) -
Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
by: Zahra Farahmandinia, et al.
Published: (2010-10-01) -
Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
by: Zahra Farahmandinia, et al.
Published: (2010-12-01)
